New plant to produce 2 billion pieces of high-quality pharmaceutical packaging per year
The plant highlights SCHOTT’s philosophy of keeping production sites close to the customers and markets. It is located at the SCHOTT Xinkang headquarters in Jinyun, Zhejiang, and will manufacture high-quality ampoules, vials and cartridges made of premium glass tubing for the domestic pharma industry.
The new production facility allows SCHOTT to continue strengthening its strategic position in the Asian pharmaceutical market and adds to the company’s global production network, which includes state-of-the-art manufacturing sites in 13 countries. This year, the group also invested in its plants in Müllheim (Germany), Lebanon (USA) and St. Gallen (Switzerland), among others.
SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 34 countries. With its workforce of approximately 15,000 employees, sales of 1.99 billion euros were generated in fiscal year 2015/2016. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.